Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study Combining Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma

NCT02352831 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT02352831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02352831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study Combining Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma
Lead sponsor
Washington University School of Medicine
Phase
Phase 1/2
Overall status
Terminated
Start date
August 31, 2015
Completion date
October 19, 2018
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of pancreas, cancer of the pancreas, pancreas cancer, pancreatic cancer